Buchman A - Search Results

1

Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients.

Jeppesen PB, Sanguinetti EL, Buchman A, Howard L, Scolapio JS, Ziegler TR, Gregory J, Tappenden KA, Holst J, Mortensen PB. Jeppesen PB, et al. Among authors: buchman a. Gut. 2005 Sep;54(9):1224-31. doi: 10.1136/gut.2004.061440. Gut. 2005. PMID: 16099790 Free PMC article. Clinical Trial.

2

Nutritional management of short bowel syndrome.

Ukleja A, Scolapio JS, Buchman AL. Ukleja A, et al. Among authors: buchman al. Semin Gastrointest Dis. 2002 Jul;13(3):161-8. Semin Gastrointest Dis. 2002. PMID: 12230319 Review.

3

Short bowel syndrome and intestinal failure: consensus definitions and overview.

O'Keefe SJ, Buchman AL, Fishbein TM, Jeejeebhoy KN, Jeppesen PB, Shaffer J. O'Keefe SJ, et al. Clin Gastroenterol Hepatol. 2006 Jan;4(1):6-10. doi: 10.1016/j.cgh.2005.10.002. Clin Gastroenterol Hepatol. 2006. PMID: 16431298

4

AGA technical review on short bowel syndrome and intestinal transplantation.

Buchman AL, Scolapio J, Fryer J. Buchman AL, et al. Gastroenterology. 2003 Apr;124(4):1111-34. doi: 10.1016/s0016-5085(03)70064-x. Gastroenterology. 2003. PMID: 12671904 Review. No abstract available.

5

Micronutrients in parenteral nutrition: too little or too much? The past, present, and recommendations for the future.

Buchman AL, Howard LJ, Guenter P, Nishikawa RA, Compher CW, Tappenden KA. Buchman AL, et al. Gastroenterology. 2009 Nov;137(5 Suppl):S1-6. doi: 10.1053/j.gastro.2009.09.001. Gastroenterology. 2009. PMID: 19874941

6

Education of gastroenterology trainees: first annual fellows' nutrition course.

Scolapio JS, Buchman AL, Floch M. Scolapio JS, et al. J Clin Gastroenterol. 2008 Feb;42(2):122-7. doi: 10.1097/MCG.0b013e3181595b6a. J Clin Gastroenterol. 2008. PMID: 18209578

7

Intestinal adaptation in short bowel syndrome.

Cisler JJ, Buchman AL. Cisler JJ, et al. J Investig Med. 2005 Dec;53(8):402-13. doi: 10.2310/6650.2005.53804. J Investig Med. 2005. PMID: 16354579 Review.

8

Advances in the management of short bowel syndrome.

Jackson C, Buchman AL. Jackson C, et al. Curr Gastroenterol Rep. 2005 Oct;7(5):373-8. doi: 10.1007/s11894-005-0006-0. Curr Gastroenterol Rep. 2005. PMID: 16168235 Review.

9

A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease.

Dotan I, Rachmilewitz D, Schreiber S, Eliakim R, van der Woude CJ, Kornbluth A, Buchman AL, Bar-Meir S, Bokemeyer B, Goldin E, Maaser C, Mahadevan U, Seidler U, Hoffman JC, Homoky D, Plasse T, Powers B, Rutgeerts P, Hommes D; Semapimod-CD04/CD05 Investigators. Dotan I, et al. Among authors: buchman al. Gut. 2010 Jun;59(6):760-6. doi: 10.1136/gut.2009.179994. Gut. 2010. PMID: 20551461 Clinical Trial.

10

Teduglutide, a novel mucosally active analog of glucagon-like peptide-2 (GLP-2) for the treatment of moderate to severe Crohn's disease.

Buchman AL, Katz S, Fang JC, Bernstein CN, Abou-Assi SG; Teduglutide Study Group. Buchman AL, et al. Inflamm Bowel Dis. 2010 Jun;16(6):962-73. doi: 10.1002/ibd.21117. Inflamm Bowel Dis. 2010. PMID: 19821509 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

568 results

Search Page

Filters